财务摘要（报告期）（Navidea Biopharmaceuticals Inc）
| 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|
| 每股指标： | |||||||
| 每股收益EPS基本(元) | 0.03 | 0.11 | -0.05 | -0.56 | -0.45 | -0.20 | -0.10 |
| 每股净资产(元) | -0.03 | -0.01 | -0.30 | -0.26 | -0.15 | -0.15 | -0.08 |
| 每股经营现金净流量(元) | - | 0.03 | -0.05 | -0.27 | -0.20 | -0.15 | -0.08 |
| 每股现金流量净额(元) | 0.02 | 0.04 | -0.06 | -0.07 | 0.01 | -0.13 | -0.10 |
| 盈利能力： | |||||||
| 销售毛利率(%) | - | - | - | -181.71 | -107.42 | 99.18 | - |
| 销售净利率(%) | - | - | - | -23,117.58 | -17,979.96 | -10,406.95 | - |
| 净资产收益率平均(%) | -39.29 | -95.75 | 16.16 | 355.34 | 461.67 | 258.06 | 238.17 |
| 总资产净利率(%) | 45.68 | 72.36 | -43.81 | -275.54 | -181.26 | -130.88 | -58.30 |
| 投入资本回报率ROIC(%) | 126.92 | 235.63 | -71.59 | -806.03 | -767.41 | -335.78 | -158.26 |
| 收益质量： | |||||||
| 营业利润／利润总额(%) | 136.23 | 169.02 | 164.08 | 92.58 | 92.80 | 98.58 | 99.73 |
| 经营活动产生的现金流量净额／营业收入(%) | - | - | - | -13,688.19 | -10,075.70 | -8,162.25 | - |
| 资本结构： | |||||||
| 资产负债率(%) | 152.29 | 109.57 | 503.26 | 286.28 | 174.57 | 269.37 | 158.56 |
| 权益乘数 | -1.91 | -10.45 | -0.25 | -0.54 | -1.34 | -0.59 | -1.71 |
| 产权比率 | -2.65 | -8.35 | -1.21 | -1.48 | -2.20 | -1.49 | -2.38 |
| 流动资产／总资产(%) | 79.02 | 85.22 | 50.58 | 73.29 | 81.49 | 46.76 | 64.50 |
| 非流动资产／总资产(%) | 20.98 | 14.78 | 49.42 | 26.71 | 18.51 | 53.24 | 35.50 |
| 流动负债／负债合计(%) | 91.93 | 92.22 | 77.64 | 79.44 | 77.18 | 78.91 | 85.80 |
| 非流动负债／负债合计(%) | 8.07 | 7.78 | 22.36 | 20.56 | 22.82 | 21.09 | 14.20 |
| 归属母公司股东的权益／投入资本(%) | -212.30 | -60.51 | -482.06 | -404.94 | -363.31 | -240.72 | -114.79 |
| 偿债能力： | |||||||
| 流动比率 | 0.56 | 0.84 | 0.13 | 0.32 | 0.60 | 0.22 | 0.47 |
| 速动比率 | 0.51 | 0.79 | 0.08 | 0.28 | 0.58 | 0.16 | 0.41 |
| 货币资金／流动负债(%) | 48.44 | 73.97 | 0.37 | 20.08 | 54.56 | 6.16 | 24.84 |
| 营业利润／流动负债(%) | -87.50 | -58.39 | -26.19 | -141.33 | -128.70 | -110.90 | -60.80 |
| 经营活动产生的现金流量净额／流动负债(%) | 1.81 | 35.74 | -18.62 | -90.39 | -77.71 | -88.23 | -52.16 |
| 归属母公司股东的权益／负债合计(%) | -37.71 | -11.98 | -82.58 | -67.41 | -45.39 | -67.21 | -42.05 |
| 经营活动产生的现金流量净额／负债合计(%) | 1.66 | 32.96 | -14.45 | -71.81 | -59.98 | -69.62 | -44.75 |
| 营业利润／负债合计(%) | -80.44 | -53.85 | -20.33 | -112.27 | -99.33 | -87.51 | -52.16 |
| 成长能力： | |||||||
| 总资产同比增长率(%) | -8.94 | 228.31 | -34.27 | -34.21 | -30.15 | -77.81 | -64.25 |
| 每股净资产同比增长率(%) | 78.80 | 92.48 | -278.57 | -7,233.66 | -236.74 | -178.89 | -153.10 |
| 总负债同比增长率(%) | -20.56 | 33.54 | 108.62 | 107.89 | 126.41 | 39.20 | 12.69 |
| 基本每股收益同比增长率(%) | 106.67 | 155.00 | 50.00 | -40.00 | -60.71 | - | 9.09 |
| 归属母公司股东的权益同比增长率(%) | 34.02 | 76.20 | -309.67 | -7,816.80 | -245.76 | -179.46 | -156.15 |
| 营业利润同比增长率(%) | 35.67 | 17.82 | 18.69 | -16.50 | -28.87 | 1.63 | 10.53 |
| 营业收入同比增长率(%) | -100.00 | -100.00 | - | -87.65 | -86.48 | -85.05 | -100.00 |
| 股东权益合计同比增长率(%) | 36.15 | 81.45 | -352.61 | -1,403.47 | -212.90 | -165.89 | -142.11 |
| 营运能力： | |||||||
| 存货周转率次(次) | - | - | - | 0.64 | 0.78 | - | - |
| 流动资产周转率次(次) | - | - | - | 0.02 | 0.01 | 0.02 | - |
| 固定资产周转率次(次) | - | - | - | 0.08 | 0.08 | 0.07 | - |
| 总资产周转率次(次) | - | - | - | 0.01 | 0.01 | 0.01 | - |
| 衍生指标： | |||||||
| 现金及现金等价物净增加额TTM(元) | -735,969.00 | 5,815,857.00 | -1,183,319.00 | -2,235,005.00 | -2,575,420.00 | -6,786,091.00 | -6,290,205.00 |
| 利润总额TTM(元) | -8,607,481.00 | -12,059,967.00 | -13,666,241.00 | -15,177,156.00 | -15,346,691.00 | -12,060,659.00 | -11,735,241.00 |
| 毛利TTM(元) | -119,295.00 | -119,295.00 | -119,295.00 | -119,295.00 | -19,521.00 | 203,783.00 | 531,513.00 |
| 投入资本(元) | 1,541,456.00 | 1,783,426.00 | 2,041,274.00 | 2,083,228.00 | 1,365,124.00 | 1,883,176.00 | 2,092,493.00 |
| 经营活动产生的现金流量净额TTM(元) | -2,288,749.00 | -1,322,822.00 | -8,152,581.00 | -8,986,570.00 | -9,281,866.00 | -9,436,224.00 | -9,711,727.00 |
| 总营业收入TTM(元) | 65,652.00 | 65,652.00 | 65,652.00 | 65,652.00 | 115,390.00 | 204,256.00 | 531,513.00 |
| 归属母公司净利润TTM(元) | -1,182,480.00 | -4,634,966.00 | -13,666,240.00 | -15,177,153.00 | -15,346,687.00 | -12,076,698.00 | -11,751,279.00 |
| 所得税TTM(元) | - | - | - | - | 16,043.00 | 16,043.00 | 16,043.00 |